Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 3
1984 1
1986 2
1988 1
1990 1
1992 1
1993 1
2000 1
2004 1
2005 2
2008 1
2009 2
2010 1
2012 1
2014 1
2015 1
2017 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
A target rash.
Lusi EA, Guarascio P. Lusi EA, et al. Among authors: guarascio p. Lancet. 2005 Feb 26-Mar 4;365(9461):784. doi: 10.1016/S0140-6736(05)17986-0. Lancet. 2005. PMID: 15733720 No abstract available.
Nickel-resistant bacteria isolated in human microbiome.
Lusi EA, Patrissi T, Guarascio P. Lusi EA, et al. Among authors: guarascio p. New Microbes New Infect. 2017 Jun 8;19:67-70. doi: 10.1016/j.nmni.2017.06.001. eCollection 2017 Sep. New Microbes New Infect. 2017. PMID: 28725438 Free PMC article.
Liver damage from verapamil.
Guarascio P, D'Amato C, Sette P, Conte A, Visco G. Guarascio P, et al. Br Med J (Clin Res Ed). 1984 Feb 4;288(6414):362-3. doi: 10.1136/bmj.288.6414.362-a. Br Med J (Clin Res Ed). 1984. PMID: 6419928 Free PMC article. No abstract available.
Peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a monotherapy in early virological responders and peginterferon alpha-2a and ribavirin versus peginterferon alpha-2a, ribavirin and amantadine triple therapy in early virological nonresponders: the SMIEC II trial in naïve patients with chronic hepatitis C.
Angelico M, Koehler-Horst B, Piccolo P, Angelico F, Gentile S, Francioso S, Tarquini P, Vecchia RD, Ponti L, Pilleri G, Barlattani A, Grieco A, Soccorsi F, Guarascio P, Demelia L, Sorbello O, Rossi Z, Forlini G, Zaru S, Bandiera F; SMIEC II Investigators. Angelico M, et al. Among authors: guarascio p. Eur J Gastroenterol Hepatol. 2008 Jul;20(7):680-7. doi: 10.1097/MEG.0b013e3282f5196c. Eur J Gastroenterol Hepatol. 2008. PMID: 18679072 Clinical Trial.
24 results